The government will sell up to 4% of its stake in Indian Railway Finance Corporation. The Offer for Sale begins Wednesday for institutional investors and Thursday for retail investors. The floor price is set at Rs 104 per share. IRFC is the funding arm for Indian Railways. The company recently reported its highest-ever quarterly profit.Read More
With improving earnings visibility and more reasonable valuations, investors can deploy fresh capital in diversified equity strategies. Multi-cap and flexi-cap funds are well-positioned to capture opportunities across market segments. Broad-based growth is expected, driven by government initiatives and potential trade deal benefits.Read More
Aequs is investing ₹230 crore in its consumer electronics division to cut debt and boost capital expenditure. The company’s aerospace segment shows strong revenue visibility with an $814 million order book. A new facility in Tamil Nadu will focus on aero engine components. Aequs aims for sustained growth by strengthening aerospace and scaling consumer electronics.Read More
After three decades in markets, Vishal Malkan emphasizes survival over prediction, highlighting psychology as key to long-term trading success. He stresses discipline, adaptability, patience, and focus, advocating for risk management and capital preservation as paramount. Malkan believes mental resilience, akin to a cricketer protecting their wicket, is crucial for navigating market volatility and achieving sustained...Read More
US equities have seen strong gains driven by AI mega-caps. Concerns about market concentration and high valuations are prompting investors to look beyond the US. Asia, including India, South Korea, and Indonesia, shows improving fundamentals. Select European markets, particularly manufacturing and defence, also present compelling opportunities for diversification in the coming months.Read More
India’s top financial institutions, LIC and mutual funds, have suffered significant losses as the Nifty IT index plunged 21%. Fears of AI disrupting the traditional IT labour-arbitrage model are driving this downturn, with analysts questioning the long-term growth prospects of major IT firms. Investors face a dilemma between beaten-down valuations and uncertain future fundamentals.Read More
Dr. Reddy’s Laboratories shares are in focus today. The US SEC has concluded its investigation into allegations of improper payments to healthcare professionals. The regulator has decided not to recommend any enforcement action against the company. This development follows an internal probe launched by Dr. Reddy’s in 2020. The company fully cooperated with the authorities...Read More
Seven Nifty500 stocks, including Natco Pharma and Bandhan Bank, formed a White Marubozu pattern on February 24, signalling strong buying interest. The bullish candlestick formation, identified through StockEdge technical scans, indicates that buyers dominated trading through the session, suggesting potential near-term upward momentum in these counters.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
